| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-24.99 |
4.34 |
-11.73 |
-11.86 |
0.14 |
|
| Diluted EPS (Rs.) |
-24.99 |
4.34 |
-11.73 |
-11.86 |
0.14 |
|
| Cash EPS (Rs.) |
-20.60 |
9.73 |
-6.23 |
-1.06 |
11.78 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
142.19 |
66.75 |
61.79 |
72.85 |
85.44 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
142.19 |
66.75 |
61.79 |
72.85 |
85.44 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
25.81 |
15.71 |
29.99 |
86.54 |
105.53 |
|
| PBDIT/Share (Rs.) |
-5.12 |
-23.37 |
0.72 |
20.11 |
22.52 |
|
| PBIT/Share (Rs.) |
-9.51 |
-28.76 |
-4.78 |
9.31 |
10.89 |
|
| PBT/Share (Rs.) |
-12.89 |
5.31 |
-21.64 |
-13.72 |
0.23 |
|
| Net Profit/Share (Rs.) |
-24.99 |
4.34 |
-11.73 |
-11.86 |
0.14 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
-19.83 |
-148.77 |
2.39 |
23.23 |
21.34 |
|
| PBIT Margin (%) |
-36.85 |
-183.10 |
-15.94 |
10.75 |
10.31 |
|
| PBT Margin (%) |
-49.92 |
33.83 |
-72.13 |
-15.85 |
0.21 |
|
| Net Profit Margin (%) |
-96.82 |
27.61 |
-39.12 |
-13.70 |
0.13 |
|
| Return on Networth / Equity (%) |
-17.57 |
6.49 |
-18.99 |
-16.28 |
0.16 |
|
| Return on Capital Employed (%) |
-6.01 |
-33.81 |
-2.96 |
4.78 |
5.00 |
|
| Return on Assets (%) |
-13.44 |
1.84 |
-4.29 |
-4.07 |
0.04 |
|
| Total Debt/Equity (X) |
0.07 |
0.36 |
2.00 |
2.07 |
1.90 |
|
| Asset Turnover Ratio (%) |
13.88 |
6.67 |
10.97 |
29.75 |
35.79 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.60 |
0.99 |
0.52 |
0.69 |
0.71 |
|
| Quick Ratio (X) |
3.02 |
0.95 |
0.30 |
0.46 |
0.43 |
|
| Inventory Turnover Ratio (X) |
1.59 |
2.26 |
1.23 |
3.77 |
4.74 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
674.08 |
1,363.81 |
2,388.72 |
1,910.78 |
1,572.97 |
|
| EV/Net Operating Revenue (X) |
4.26 |
14.18 |
13.00 |
3.60 |
2.43 |
|
| EV/EBITDA (X) |
-21.50 |
-9.53 |
543.39 |
15.52 |
11.39 |
|
| MarketCap/Net Operating Revenue (X) |
4.24 |
12.62 |
8.90 |
1.86 |
0.88 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
0.77 |
2.97 |
4.32 |
2.21 |
1.09 |
|
| Price/Net Operating Revenue |
4.24 |
12.62 |
8.90 |
1.86 |
0.88 |
|
| Earnings Yield |
-0.23 |
0.02 |
-0.04 |
-0.07 |
0.00 |
|
Source : Dion Global Solutions Limited
